Syndecan-1

Updated: 2026-07-20

Overview

Syndecan-1 (SDC1) is a cell surface heparan sulfate proteoglycan belonging to the syndecan family. It consists of a core protein with attached glycosaminoglycan (GAG) chains, primarily heparan sulfate. SDC1 is expressed in epithelial cells and plasma cells, where it mediates cell-matrix interactions and modulates signaling pathways. As a co-receptor, SDC1 binds growth factors (e.g., FGF2, VEGF) and extracellular matrix components, influencing cell proliferation, migration, and differentiation. Its soluble form, shed via proteolysis, serves as a biomarker in diseases like multiple myeloma and epithelial cancers.

Physical and Chemical Properties

SDC1 is a type I transmembrane protein with a molecular weight of ~80-100 kDa, varying due to extensive post-translational glycosylation. The extracellular domain bears 3-5 heparan sulfate chains, contributing to its negative charge and ligand-binding capacity. The protein is stable in neutral buffers (pH 7-8) but susceptible to degradation by heparanase or matrix metalloproteinases (MMPs). Its solubility depends on buffer ionic strength, with precipitation risks at high salt concentrations. Lyophilized formulations typically contain stabilizers like BSA or trehalose.

Main Applications

In research, SDC1 is used to study tumor metastasis, angiogenesis, and inflammatory responses. It is a diagnostic marker for plasma cell disorders (e.g., CD138 in multiple myeloma) and epithelial cancers (e.g., breast, lung). Therapeutically, SDC1 is explored as a target for antibody-drug conjugates (ADCs) and heparanase inhibitors. Its role in viral entry (e.g., SARS-CoV-2) also makes it relevant to infectious disease research. Recombinant SDC1 is employed in vitro to investigate ligand-receptor interactions.

Safety and Storage

SDC1 poses minimal biohazard risk but should be handled using standard laboratory precautions (gloves, goggles). Avoid inhalation of lyophilized powder. Store lyophilized protein at -20°C or -80°C; reconstituted solutions are stable for 1-2 weeks at 4°C with protease inhibitors. Aliquot to prevent repeated freeze-thaw cycles. Contamination risks include endotoxins (critical for cell assays) and microbial growth in unpreserved solutions.

B2B Procurement Guide

When sourcing SDC1, prioritize suppliers with ISO 13485 certification for consistency. Key specifications include purity (>95% by SDS-PAGE), endotoxin levels (<1 EU/μg), and activity validation (e.g., FGF2 binding assays). For therapeutic development, ensure compliance with cGMP standards. Bulk orders (10+ mg) may qualify for discounted pricing. Consider recombinant variants (e.g., human SDC1 ectodomain) for specific applications. Lead times vary; custom services (e.g., biotinylation) may extend delivery by 4-6 weeks.